Did Reformulated OxyContin Really Discourage Abuse? FDA advisors to review Purdue Pharma's flagship product, redesigned in 2010 to resist snorting and injection Sep 09, 2020
FDA Drops Boxed Warning From Invokana Label Amputation risk "lower than previously described" Aug 27, 2020
FDA OKs Anti-BCMA Drug for Multiple Myeloma Accelerated approval for belantamab mafodotin after four other therapies Aug 06, 2020
Triplet OK'd as First-Line Therapy in Melanoma Immunotherapy plus targeted combo nets FDA approval in BRAF-mutant population Jul 31, 2020
Essure Linked to Higher Rates of Abnormal Uterine Bleeding and Chronic Pain Early results of a post-market analysis show adverse effects after years of FDA action Jul 14, 2020
Heat-Not-Burn Cigarettes Win Coveted Marketing Claims FDA allows Marlboro Heatstick labels to boast "reduced exposure" though not "reduced risk" Jul 07, 2020
FDA Slaps Stem Cell Firm Linked to Nebraska Infections EUCYT Laboratories also pushing exosome treatments for COVID-19 Jun 23, 2020
HCQ No Longer Approved Even a Little for COVID-19 Study after study showed no benefit, and now the FDA has had enough Jun 15, 2020
New NMO Drug Gets FDA Nod B-cell depleting inebilizumab is the second neuromyelitis optica spectrum disorder treatment approved Jun 12, 2020
Telemedicine Abortion Gains Momentum During Pandemic But FDA regulations on mifepristone still limit access Jun 02, 2020
NDMA Prompts Metformin Recall FDA finds certain products with excessive levels of potential carcinogen May 29, 2020
Alzheimerβs Tau Tracer Wins Landmark Approval "Major advance" toward diagnosing Alzheimer's with brain imaging May 29, 2020
Push Needed for At-Home Coronavirus Antibody Testing An opportunity for the U.S. to catch up Apr 15, 2020
Chloroquine Is Not a Harmless Panacea for COVID-19 There's a real safety concern with malaria drug Mar 23, 2020
Montelukast Warning Upgraded Existing risk information not prominent enough and needs a black box, FDA decides Mar 04, 2020
Spravato Debate Still Rages Journal airs questions about efficacy data, potential for harm Feb 20, 2020
Will Palforzia Revolutionize Peanut Allergy Tx? FDA approves first-ever peanut immunotherapy, but wide adoption uncertain Feb 03, 2020
How We Used FDA MAUDE Data on NovaSure Attuned to limitations, investigative team used conservative approach Jan 29, 2020
How to Handle a Heparin Shortage: Effective Strategies With supply chain issues in China, it's a real threat, group says Jan 27, 2020
Meet the 'Lien Doctors'; Hidden Clinical Trial Data; Google Nabs More Medical Records This past week in healthcare investigations Jan 15, 2020
Serious Illnesses in Nebraska Tied to Exosome Therapy New trend in unapproved stem cell therapy led to sepsis in some patients Dec 16, 2019
FDA Warns Alkermes on Vivitrol Ads Campaign omits important risk information, agency says Dec 12, 2019
FDA Warns Liveyon Over Cord Blood Stem Cell Products Company slapped for distributing unapproved products, deviating from quality manufacturing practices Dec 09, 2019
European 'Brain-Boosting' Drug Pushed as Supplement in U.S. Study finds FDA-rejected supplement can deliver doses high above EU-approved range Nov 25, 2019
Watchman: Sicker Patients, More Deaths Than in Trials Medicare data paint a different picture of the LAA occluder Oct 31, 2019
Mila's N-of-1 Trial Detailed in NEJM Neurologic scores stabilized, seizures diminished with tailored antisense oligonucleotide therapy Oct 09, 2019
Does Zantac Break Down Into a Carcinogen? Rather than contamination, "the fundamental problem is that it's an unstable molecule" Oct 03, 2019
Mitral Valve Procedure Learning Curve Raises Access Question And guess which procedures are next for public outcome reporting... Sep 27, 2019
Risk-Based Thresholds for hs-Troponin I Safely Speed MI Rule-Out HISTORIC suggests benefit to patients, clinicians Sep 01, 2019
Should the Elderly Discontinue Statins? The debate goes on, but Kevin Campbell, MD, believes every patient is different Aug 14, 2019 video
Want a Glimpse of Single-Payer Healthcare? Look at Cuba The distinction between single-payer and universal care is critical, says Niran S. Al-Agba, MD Jul 09, 2019
Asthma Specialists Attack Return of Primatene Mist FDA approval process, clinical need questioned in commentary Jul 07, 2019
How Common Are Accutane-Related Psychiatric Events? Difficult to untangle whether increased cases of depression, suicide are related to treatment or acne itself Jul 03, 2019
Protesters Rally, Disrupt Opening Session at AMA Meeting Activists urge the association to support Medicare for All Jun 08, 2019
First Drug OK'd for Cluster Headache Prevention CGRP inhibitor reduces attack frequency in episodic disorder Jun 05, 2019